Breaking News
-
Bio News | Breaking News | Drug Development | Drug Discovery | Industry News | R&D
Exscientia Launches New Subsidiary
Exscientia K.K will spearhead the company's pharmaceutical interests across Asia03.25.19
-
Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Swedish Biomimetics Establishes Continuous Peptide Mfg. Process
μLOT platform achieves manufacture of complex peptides with reduced costs and improved quality and control03.25.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Abzena Launches Developability and Optimization Service
Designed to improve lead selection and de-risk biologic cell line development03.25.19
-
Breaking News | Drug Development | Industry News | Laboratory Testing
Thermo Fisher Acquires Brammer Bio in $1.7B Deal
The viral vector manufacturer for gene and cell therapies will join Thermo's Laboratory Products and Services Segment03.25.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Celgene Enters AI Drug Discovery Deal with Exscientia
Collaboration focused on accelerating drug discovery in oncology and autoimmunity03.25.19
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | R&D
LegoChem, Takeda Enter ADC Cancer Research Collaboration
Will focus on the development of antibody drug conjugates in immuno-oncology03.25.19
-
Breaking News | Promotions & Moves
Paragon Bioservices Appoints New CTSO
Bolsters leadership ranks to support late-stage clinical and commercial biopharma manufacturing03.22.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities
bluebird bio Opens Gene and Cell Therapy Mfg. Facility
NC's Gov. Cooper to cut ribbon on facility that will strengthen bluebird's capabilities to make products for clinical devt. and commercial supply03.22.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Abzena, Lipum Sign Integrated CMC Agreement
Will produce a novel biologic for autoimmune inflammatory diseases03.22.19
-
Breaking News | Industry News
Biogen, Eisai End Phase III aducanumab Trials in AD
Decision was based on results of a futility analysis conducted by an independent data monitoring committee03.22.19
-
Breaking News | Collaborations & Alliances | Industry News
Alvogen Investment Bolsters Asian Presence
Enters cross-investment partnership with Fuji to enhance market access to fast-growing Asian pharma market03.21.19
-
Breaking News | Facilities | Industry News | Inspections
Flamma Completes Successful CFDA Inspection
Milestone is part of the Flamma 2020 Plan to bring improvement across the CDMO’s network of manufacturing sites03.21.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Preclinical Outsourcing | Process Development
WuXi STA Forms Partnership with Beta Pharma
STA will accelerate process R&D and manufacturing of late phase and commercial targets03.21.19
-
APIs | Breaking News | Industry News
Flamma Opens New cGMP Kilo Lab in Italy
Plans construction of new R&D building to quadruple space03.20.19
-
Breaking News | Collaborations & Alliances | Drug Development
Takeda, HemoShear Expand NASH Pact
Several drug targets shown to inhibit biological processes associated with inflammation and fibrosis that can lead to nonalcoholic steatohepatitis03.20.19
-
Breaking News | Drug Development | Industry News
Petra Pharma Licenses Takeda’s Serabelisib
Researching new approaches that have the potential to increase tumor responses with PI3K inhibitors and minimize side effects03.20.19
-
Breaking News | cGMP Manufacture | Industry News
WuXi Biologics Receives EMA GMP Certificates for Trogarzo
To provide cGMP Drug Substance and Drug Product manufacturing at Wuxi city and cGMP cell banking facilities in Shanghai03.20.19
-
Breaking News | cGMP Manufacture | Industry News | Process Development | Scale-up/Technology Transfer
MilliporeSigma Opens New M Lab Collaboration Center in France
Provides customers with a fully equipped, non-GMP pilot and bench scale lab to help address processing development challenges03.20.19
-
Breaking News | Industry News
Thermo Fisher Expands Pharma Services Biz
Invests $150 million in sterile liquid and lyophilized product development and commercial manufacturing in Italy and Greenville, NC03.20.19
-
APIs | Breaking News | Collaborations & Alliances | Industry News
